Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket



  • Jeffs' Brands Ltd JFBR rose 76.5% to $2.70 in pre-market trading after jumping 19% on Friday.
  • Pliant Therapeutics, Inc. PLRX rose 48.8% to $33.49 in pre-market trading after the company announced data from the integris-IPF Phase 2a trial demonstrating bexotegrast 320 mg was well tolerated and achieved statistically significant FVC increase in patients with idiopathic pulmonary fibrosis.
  • Helbiz, Inc. HLBZ rose 46.9% to $0.2993 in pre-market trading. Helbiz shares jumped 65% on Friday after the company said its Board of Directors has begun examining measures to address alleged illegal short selling of its stock.
  • Allarity Therapeutics, Inc. ALLR rose 35.9% to $0.3450 in pre-market trading after gaining over 16% on Friday. Allarity Therapeutics announced adjournment of 2023 annual meeting of stockholders.
  • Boxed, Inc. BOXD shares rose 34.3% to $0.6351 in pre-market trading after the company reported up to $20 million of new financing.
  • Genius Group Limited GNS shares rose 22.2% to $3.96 in pre-market trading. Genius Group shares jumped 55% on Friday on continued strength after the company approved a plan to create an 'Illegal Trading Task Force.'
  • WiSA Technologies, Inc. WISA rose 13.6% to $0.16 in pre-market trading after jumping 14% on Friday.
  • Digital Brands Group, Inc. DBGI shares rose 10.6% to $2.85 in pre-market trading. DBG recently announced closing of $5.0 million private placement priced at-the-market under Nasdaq rules.
  • Exela Technologies, Inc. XELA rose 7.4% to $0.0799 in pre-market trading. Exela Technologies recently signed a strategic partnership with Quintes Global.
  • Tritium DCFC Limited DCFC rose 5.3% to $1.38 in pre-market trading. The company recently reported FY22 preliminary sales of $95 million to $102 million.


  • Apexigen, Inc. APGN fell 12% to $1.76 in pre-market trading. Apexigen recently announced new Phase 2 data evaluating sotigalimab, its CD40 agonist antibody, at ASCO Gastrointestinal Cancers Symposium 2023.
  • Cosmos Health Inc. COSM shares fell 10.8% to $4.75 in pre-market trading. Cosmos Health shares jumped 72% on Friday after the company updated the payment terms of its agreement to acquire ZipDoctor.
  • Eargo, Inc. EAR fell 9.7% to $13.13 in pre-market trading after jumping 26% on Friday. The company recently effected a 1:20 reverse stock split.
  • Ontrak, Inc. OTRK fell 8.5% to $0.97 in pre-market after declining around 12% on Friday. Ontrak recently announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
  • TC Biopharm (Holdings) Plc TCBP fell 7.3% to $4.26 in pre-market trading after dropping around 12% on Friday. TC BioPharm recently received a notice of non-compliance with NASDAQ's Listing Rule 5550(b)(1).
  • AppHarvest, Inc. APPH fell 6.2% to $1.52 in pre-market trading after jumping over 16% on Friday. AppHarvest said on January 11, that it received notice from Nasdaq that the company has not been in compliance with minimum bid price requirement.
  • OceanPal Inc. OP shares dropped 6.1% to $0.8830 in pre-market trading. OceanPal recently regained compliance with Nasdaq minimum bid price requirement.
  • Rigetti Computing, Inc. RGTI fell 5.9% to $0.84 in pre-market trading.
  • NeuroSense Therapeutics Ltd. NRSN shares fell 4.5% to $1.70 in pre-market trading after dipping around 20% on Friday. NeuroSense Therapeutics recently reported final results from its Alzheimer's biomarker study.
  • Grom Social Enterprises, Inc. GROM fell 4.1% to $1.65 in pre-market trading after gaining 6% on Friday.

Now Read This: Fear & Greed Index Moves To 'Greed' Zone As Nasdaq Record Gains For Third Straight Week

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!